All Stories

  1. Tocilizumab, MS, and NMOSD

    Article • Multiple Sclerosis Journal, July 2016, SAGE Publications

    Ingo Kleiter

  2. Fingolimod review

    Article • Therapeutics and Clinical Risk Management, February 2016, Dove Medical Press

    Ingo Kleiter

  3. Predictors for multiple sclerosis relapses after switching from natalizumab to fingolimod

    Article • Multiple Sclerosis Journal, May 2014, SAGE Publications

    Ingo Kleiter

  4. Bridging, switching or drug holidays – how to treat a patient who stops natalizumab?

    Article • Therapeutics and Clinical Risk Management, October 2013, Taylor & Francis

    Ingo Kleiter